Home D Cardiovascular Conditions Degenerative mitral regurgitation: Symptoms, Atrial Fibrillation Risk, and When to Intervene

Degenerative mitral regurgitation: Symptoms, Atrial Fibrillation Risk, and When to Intervene

By
Vita Library
-
71

Degenerative mitral regurgitation is a common form of “leaky” mitral valve disease that develops when the valve’s own tissue weakens over time. Mitral regurgitation (blood leaking backward through a valve) can be surprisingly silent at first. Many people adjust without noticing—slowing their pace, taking more breaks, or blaming mild breathlessness on age or fitness. Meanwhile, the heart may be working harder to compensate, and the risk of rhythm problems can quietly rise.

The encouraging part is that degenerative mitral regurgitation is often highly treatable—especially when it is recognized before the heart muscle weakens. This article explains what happens inside the heart, why the leak develops, who is most at risk, the symptoms that should trigger evaluation, how clinicians confirm severity, and what modern treatment and long-term management typically involve.

Table of Contents

What degenerative mitral regurgitation does

The mitral valve sits between the left atrium and left ventricle. It opens to let blood flow into the ventricle, then closes tightly so blood can be pumped forward into the aorta. In degenerative mitral regurgitation (often called “primary” MR), the valve itself is the problem: the leaflets, supporting cords (chordae), or ring-like base (annulus) become stretched or weakened. When the ventricle squeezes, part of the blood leaks backward into the left atrium instead of moving forward.

At first, the body compensates. The left ventricle may pump a larger total volume so that enough blood still moves forward. The left atrium may enlarge to accommodate the extra blood returning with each beat. This compensation is why many people feel normal for years—even when the leak is significant on echocardiography.

Over time, however, chronic volume overload can create predictable stress points:

  • Left atrial enlargement increases the risk of atrial fibrillation, a common rhythm disturbance that can cause palpitations, fatigue, and stroke risk.
  • Higher pressures in the lungs can develop as left atrial pressure rises, causing exertional breathlessness and sometimes pulmonary hypertension.
  • Left ventricular remodeling can shift from “adaptive” to “failing.” When the ventricle begins to weaken, symptoms can accelerate, and outcomes worsen if repair is delayed.
  • Right heart strain may appear later when lung pressures stay high, leading to swelling, abdominal fullness, and reduced stamina.

A key insight with degenerative MR is timing. Unlike many chronic conditions where clinicians “wait until symptoms,” valve disease is different. When MR is severe, waiting too long can allow irreversible changes in the heart muscle and lungs. That is why modern care often recommends earlier intervention—especially when a durable mitral valve repair is likely—before the ventricle loses strength.

It also helps to distinguish degenerative MR from secondary (functional) MR. In secondary MR, the valve may be structurally normal, but the ventricle is enlarged or weakened, pulling the valve open. Degenerative MR is primarily a valve-tissue problem, which is one reason repair outcomes can be excellent when performed by experienced teams.

Back to top ↑

Why the mitral valve becomes leaky

Degenerative mitral regurgitation usually develops because the valve’s connective tissue changes over time. The leaflets can become thickened and floppy, the chordae can stretch or rupture, and the annulus can dilate. When the valve closes, these changes prevent a tight seal and allow backward flow.

Two common degenerative patterns are often discussed:

  • Myxomatous degeneration: the leaflets become redundant and “billowy,” and the chords may elongate. This often underlies classic mitral valve prolapse, where part of the leaflet bows back toward the left atrium during contraction.
  • Fibroelastic deficiency: the tissue is thinner and less robust, and a single chord may rupture, leading to a sudden flail leaflet and abrupt worsening of regurgitation.

These patterns matter because they influence how MR presents. A slow, progressive prolapse may be silent for years. A chordal rupture can cause sudden breathlessness, cough, and fatigue over days to weeks, sometimes after a seemingly minor trigger.

Degenerative MR is not typically caused by infection, rheumatic fever, or heart attack—though those can cause MR through different mechanisms. Degenerative disease is mainly a structural aging process, sometimes influenced by inherited connective-tissue traits.

In clinical decision-making, the “cause” of MR is confirmed by imaging rather than assumptions. Echocardiography can show the specific mechanism:

  • Prolapse of the posterior leaflet (a common repair-friendly pattern)
  • Anterior leaflet prolapse (often repairable but sometimes more complex)
  • A flail segment from ruptured chordae (often severe and symptomatic)
  • Annular dilation contributing to poor coaptation (leaflets not meeting)

It is also useful to understand what does not reliably prevent degenerative MR from developing. There is no proven medication that stops valve degeneration. Treating blood pressure and maintaining cardiovascular fitness support the heart, but they do not “strengthen” valve tissue in a way that reverses prolapse or chordal stretching.

That said, early detection still matters because it shifts the course. When clinicians can track severity and heart response over time, they can recommend intervention at a point where repair is safer, recovery is smoother, and long-term heart function is more likely to remain normal.

Back to top ↑

Risk factors and who needs follow-up

Degenerative mitral regurgitation becomes more common with age, but several factors raise the likelihood of developing significant disease or progressing to complications. Risk is not just about “getting MR”—it is also about how the heart responds to the leak.

Non-modifiable risk factors include:

  • Age, especially midlife and older adulthood
  • Sex differences in presentation (patterns vary; women may present later with different symptom profiles)
  • Family history of mitral valve prolapse or early valve surgery
  • Connective tissue traits, including certain inherited syndromes (in some patients)
  • Valve anatomy: larger prolapsing segments or multi-scallop involvement may be more likely to progress

Factors that influence progression and complications include:

  • Severity of regurgitation at diagnosis (mild vs moderate vs severe)
  • Enlargement of the left atrium, which raises atrial fibrillation risk
  • Early signs of left ventricular strain or subtle decline in function
  • Higher pulmonary pressures at rest or with exercise
  • New rhythm disturbances, particularly atrial fibrillation

Who should be evaluated or monitored?
People often discover a murmur during a routine exam or an echocardiogram ordered for palpitations. Follow-up is especially important for:

  • Anyone with moderate or severe MR on echocardiography
  • Anyone with mitral valve prolapse plus symptoms (palpitations, breathlessness, chest discomfort)
  • People with new atrial fibrillation, especially if an echo shows mitral regurgitation and atrial enlargement
  • Individuals with sudden symptom onset (possible chord rupture and flail leaflet)
  • Those with a history of endocarditis risk factors or prior valve infection (not the typical degenerative pathway, but affects management)

A common real-world issue is under-recognition of symptoms. People with chronic MR may unconsciously reduce activity. Clinicians often ask functional questions to surface this: “What did you stop doing this year?” or “How many flights of stairs can you climb without stopping now compared with last year?”

Another key risk factor is the availability of high-quality repair. Degenerative MR has one of the clearest links between operator experience and outcomes. When a center has a high likelihood of durable repair with low complication rates, clinicians can recommend earlier surgery for severe MR in selected patients, even if symptoms are minimal, to protect long-term heart function.

If you have known degenerative MR, the best “risk reduction” is a structured follow-up plan: periodic echocardiography, rhythm monitoring when indicated, and early discussion with a valve team if severity increases or the heart begins to remodel.

Back to top ↑

Symptoms and complications to know

Symptoms of degenerative mitral regurgitation often develop gradually, and the first changes can be easy to misinterpret. Many people do not feel breathless at rest; instead, they notice that exertion feels “heavier” or recovery takes longer. Symptoms also tend to accelerate once the heart’s compensation begins to fail.

Common symptoms include:

  • Shortness of breath with activity, especially climbing stairs or walking uphill
  • Fatigue, reduced stamina, or needing longer rest after exertion
  • Palpitations (fluttering, racing, or irregular heartbeat)
  • Reduced exercise capacity compared with peers or your past baseline
  • Cough, especially at night, in more advanced cases

If regurgitation worsens suddenly—such as with chordal rupture—symptoms can appear abruptly:

  • Rapid onset breathlessness, sometimes with frothy sputum
  • New inability to lie flat comfortably
  • A sense of chest congestion or “air hunger” with minimal activity

Complications often revolve around three areas: rhythm, lungs, and ventricular function.

  1. Atrial fibrillation (AF)
    As the left atrium enlarges, the electrical pathways become more prone to AF. AF can cause fatigue, breathlessness, and palpitations, and it increases stroke risk. New AF in someone with severe degenerative MR is often a sign that the condition is moving into a higher-risk phase and may change treatment timing.
  2. Pulmonary hypertension and right-heart strain
    Backflow raises left atrial pressure, which can transmit pressure into the lungs. Over time, this can elevate pulmonary pressures and strain the right side of the heart. People may develop swelling in legs, abdominal fullness, and more pronounced breathlessness.
  3. Left ventricular dysfunction
    The left ventricle may look “strong” for a long time because it is pumping blood both forward and backward. This can mask early weakening. When true dysfunction appears, it may signal that the heart has passed an inflection point. That is why clinicians look not only at symptoms but also at objective markers of ventricular size and function.

Other potential issues include infective endocarditis risk (particularly in those with prior infection) and progressive valve changes that reduce repair options if intervention is delayed.

When to seek urgent care
Seek immediate evaluation if you have known or suspected MR and develop:

  • Sudden severe shortness of breath, especially if you cannot lie flat
  • Chest pain with breathlessness, sweating, or faintness
  • Fainting or near-fainting
  • Rapid, sustained palpitations with dizziness or weakness
  • New one-sided weakness, trouble speaking, or facial droop (possible stroke symptoms)

For non-emergency but prompt attention, contact your clinician if you notice a steady decline in exercise tolerance, new palpitations, or swelling. In degenerative MR, early response can preserve more heart function and widen treatment options.

Back to top ↑

How it’s diagnosed and measured

Diagnosing degenerative mitral regurgitation requires two decisions: confirming the mechanism (what is wrong with the valve) and quantifying severity (how much blood is leaking backward). Echocardiography is the central tool because it can show anatomy and flow in real time.

1) Clinical evaluation
A clinician may first suspect MR after hearing a systolic murmur. However, murmur intensity does not perfectly track severity. Some severe MR produces a softer murmur if the pressures equalize quickly. Symptoms and physical exam guide testing urgency, but imaging confirms the diagnosis.

2) Transthoracic echocardiography (TTE)
TTE evaluates:

  • Leaflet motion (prolapse, flail, restriction)
  • Chordae and annulus anatomy
  • Direction and size of the regurgitant jet
  • Left atrial size and left ventricular size/function
  • Pulmonary pressures and right-heart response
  • Coexisting valve disease

Severity is graded using an integrated approach rather than a single measurement. Clinicians may use color Doppler appearance, vena contracta width, quantitative measures (such as effective regurgitant orifice area and regurgitant volume), and supportive findings like atrial/ventricular enlargement.

3) Transesophageal echocardiography (TEE)
TEE provides higher-resolution images and is often used when:

  • TTE images are limited
  • Surgical or transcatheter repair is being planned
  • The mechanism is complex (for example, multiple segments, anterior leaflet involvement)
  • There is a need to rule out endocarditis-related complications

4) Stress testing and rhythm assessment
Some patients report no symptoms, yet they show limitation on exercise testing. Stress echocardiography can reveal rising pulmonary pressures or worsening MR with exertion. Rhythm monitoring (Holter or patch monitor) is used when palpitations occur or when atrial fibrillation is suspected.

5) Why “normal EF” can mislead
In chronic severe MR, the ejection fraction (EF) can look normal or high because the ventricle is ejecting blood into a low-resistance path (back into the atrium). A “normal EF” does not always mean the ventricle is healthy. Clinicians track ventricular size, function trends over time, and sometimes strain measures to detect early decline.

6) Follow-up intervals
Monitoring frequency depends on severity and heart response:

  • Mild MR may need periodic recheck over years
  • Moderate MR usually needs more regular surveillance
  • Severe MR often requires closer follow-up and early referral to a valve team, even if symptoms seem mild

Clear measurement and consistent follow-up are what make degenerative MR manageable. The goal is to choose the right moment for intervention—before the heart pays an irreversible price.

Back to top ↑

Treatment options and ongoing management

Treatment for degenerative mitral regurgitation depends on severity, symptoms, heart remodeling, rhythm status, and the likelihood of durable repair. The most important principle is that medications can support the heart, but they do not fix a structurally leaky degenerative valve. Definitive treatment is usually valve repair or, less ideally, replacement.

1) Watchful waiting with structured monitoring
For mild or moderate MR—and for some cases of severe MR without symptoms and without evidence of heart strain—clinicians may recommend careful surveillance. This is not passive. A good plan includes:

  • Scheduled echocardiography at intervals matched to severity
  • Symptom check-ins focused on real-life function
  • Rhythm monitoring if palpitations occur or atrial enlargement is present
  • Clear triggers for referral to a valve team (new symptoms, atrial fibrillation, rising pulmonary pressures, or ventricular enlargement)

2) Mitral valve repair: preferred when feasible
For severe degenerative MR, repair is often the best option when a high-quality repair is likely. Repair preserves the patient’s own valve, avoids many long-term issues associated with prosthetic valves, and can provide excellent durability—especially for common patterns like posterior leaflet prolapse. Repair techniques may include annuloplasty rings, chordal replacement, leaflet resection, or other tailored approaches.

Timing matters. Repair is often recommended when:

  • Severe MR causes symptoms
  • Severe MR leads to ventricular enlargement or declining function
  • New atrial fibrillation develops
  • Pulmonary pressures rise
  • The valve anatomy is highly repairable at an experienced center, even if symptoms are minimal

3) Valve replacement
Replacement is used when repair is not feasible or not durable. Options include mechanical or bioprosthetic valves, each with trade-offs (lifelong anticoagulation for mechanical valves, limited durability for bioprosthetic valves). The choice depends on age, bleeding risk, lifestyle preferences, and other medical factors.

4) Transcatheter edge-to-edge repair (TEER)
Some patients—especially older adults or those at high surgical risk—may be candidates for a transcatheter “clip” approach that reduces regurgitation without open surgery. TEER can improve symptoms and quality of life in appropriately selected degenerative MR patients, though it may not reduce MR as completely as a surgical repair in many cases. Anatomy and operator experience strongly influence results.

5) Medications and rhythm management
Medications are often used to manage consequences of MR:

  • Diuretics for congestion and breathlessness
  • Blood pressure control to reduce strain on the heart
  • Rate/rhythm control for atrial fibrillation
  • Anticoagulation when atrial fibrillation is present and stroke risk warrants it

6) Lifestyle and prevention
Daily management includes:

  • Staying physically active within your tolerance, avoiding sudden all-out exertion if symptomatic
  • Maintaining dental health and seeking prompt evaluation for fevers, because valve infections can be serious
  • Tracking symptoms with simple markers: walking distance, stair tolerance, sleep position, swelling, and palpitations

When to seek care quickly
Contact your clinician promptly for new or worsening breathlessness, swelling, rapid palpitations, or a drop in exercise capacity. Seek emergency care for severe breathlessness, fainting, chest pain with shortness of breath, or stroke symptoms.

Degenerative mitral regurgitation is often a condition where the right procedure at the right time preserves decades of heart function. The best outcomes usually come from early referral to a valve team once MR is severe, even if symptoms feel manageable.

Back to top ↑

References

Disclaimer

This article is for educational purposes only and does not provide medical advice, diagnosis, or treatment. Degenerative mitral regurgitation can lead to heart failure, atrial fibrillation, stroke risk, and progressive heart muscle changes. Decisions about monitoring frequency, exercise safety, medications, anticoagulation, and whether to pursue surgical repair, transcatheter repair, or valve replacement must be individualized by a qualified clinician, ideally a cardiologist and valve team experienced in mitral disease. Seek urgent medical attention for sudden severe shortness of breath, fainting, chest pain with breathing difficulty, or signs of stroke.

If you found this article helpful, please share it on Facebook, X (formerly Twitter), or any platform you prefer, and follow us on social media. Your support by sharing helps our team continue producing reliable, high-quality health content.

RELATED ARTICLESMORE FROM AUTHOR